<<VOLVER
Miguel Martin
Hospital General Universitario Gregorio Marańón, Madrid, Spain
Introduction
Aleix Prat
Hospital General Vall d’Hebron, Barcelona, Spain
Genomic landscape of breast cancer
Nicholas Turner
Royal Marsden Hospital and Institute of Cancer Research, London, UK
Targeting the PI3K–mTOR pathway
Eva Carrasco
Spanish Breast Cancer Research Group (GEICAM), Madrid, Spain
Academic research in Europe
Robert Comis
Eastern Cooperative Oncology Group (ECOG), Philadelphia, USA
Academic research in North America
Carlos H. Barrios
PUCRS School of Medicine, Porto Alegre, Brasil
Academic research in South America
Miguel Martin
Hospital General Universitario Gregorio Marańón, Madrid, Spain
Genomic platforms in early breast cancer
Jonas Bergh
Karolinska Institutet, Stockholm, Sweden
Adjuvant therapy for early breast cancer:
lessons from the EBCTCG dataset
Sibylle Loibl
German Breast Group, Neu-Isenburg, Germany
Neoadjuvant chemotherapy as a research model
Luís Costa
Hospital Santa Maria, Instituto de Medicina Molecular, Lisbon, Portugal
Treatment of bone metastases from breast cancer
Angelo di Leo
Hospital of Prato, Istituto Toscano Tumori, Prato, Italy
Hormonal therapy of metastatic breast cancer:
what is new?
Guy Jerusalem
Centre Hospitalier Universitaire du Sart-Tilman, Ličge, Belgium
New chemotherapy drugs in metastatic breast cancer
<<VOLVER